Lobbying Spend
—
Filings
22
Firms Hired
2
Active Period
2011–2015
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Combination Drug Development Incentive Act of 2013
2015 · first_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Support H.R. 2985, The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
Client expense: — · Firm income: $24,000
Matched citations: H.R. 2985
Combination Drug Development Incentive Act of 2013
2015 · first_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Support H.R. 2985, The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
Client expense: — · Firm income: $24,000
Matched citations: H.R. 2985
Combination Drug Development Incentive Act of 2013
2014 · fourth_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
Client expense: — · Firm income: $36,000
Matched citations: H.R. 2985
Combination Drug Development Incentive Act of 2013
2014 · fourth_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
Client expense: — · Firm income: $36,000
Matched citations: H.R. 2985
Combination Drug Development Incentive Act of 2013
2014 · third_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Support H.R.2985, The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
Client expense: — · Firm income: $36,000
Matched citations: H.R.2985
Combination Drug Development Incentive Act of 2013
2014 · third_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Support H.R.2985, The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
Client expense: — · Firm income: $36,000
Matched citations: H.R.2985
Combination Drug Development Incentive Act of 2013
2014 · second_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
Client expense: — · Firm income: $36,000
Matched citations: H.R. 2985
Combination Drug Development Incentive Act of 2013
2014 · second_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
Client expense: — · Firm income: $36,000
Matched citations: H.R. 2985
Combination Drug Development Incentive Act of 2013
2014 · first_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
Client expense: — · Firm income: $36,000
Matched citations: H.R. 2985
Combination Drug Development Incentive Act of 2013
2014 · first_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
Client expense: — · Firm income: $36,000
Matched citations: H.R. 2985
Combination Drug Development Incentive Act of 2013
2013 · fourth_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
Client expense: — · Firm income: $36,000
Matched citations: H.R. 2985
Combination Drug Development Incentive Act of 2013
2013 · fourth_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
Client expense: — · Firm income: $36,000
Matched citations: H.R. 2985
Combination Drug Development Incentive Act of 2013
2013 · third_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
Client expense: — · Firm income: $36,000
Matched citations: H.R. 2985
Combination Drug Development Incentive Act of 2013
2013 · third_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
Client expense: — · Firm income: $36,000
Matched citations: H.R. 2985
Source: Senate LDA